RHYTHM PHARMACEUTICALS, INC. (RYTM) Gross margin 2021–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) gross margin by fiscal year — reported gross profit divided by reported revenue.
89.7%FY2025 · since FY2021: 81.0% → 89.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 89.7% | +0.0 pp |
| FY2024 | 89.7% | +1.7 pp |
| FY2023 | 88.0% | -3.0 pp |
| FY2022 | 91.0% | +10.0 pp |
| FY2021 | 81.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RYTM financial trends
RYTM RevenueRYTM Net incomeRYTM Net marginRYTM Gross profitRYTM Operating incomeRYTM Operating marginRYTM Operating cash flowRYTM Free cash flowRYTM Capital expendituresRYTM Return on equityRYTM Stock buybacksRYTM Dividends paidRYTM Total assetsRYTM Total liabilitiesRYTM Shareholders’ equityRYTM overview →